Physician profile
John N Hsiang
NPI 1154485001
$23,340.84
in general payments reported to CMS, 2019-2025
3 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,024 · 2020: $5,195 · 2021: $2,638 · 2022: $4,338 · 2023: $4,155 · 2024: $842 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4,997 · Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,997.35 |
| Food and Beverage | $149.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $22,349.84 | 2019-2023 | Monolith |
| Globus Medical, INC. | $842.00 | 2024 | Monolith |
| Gilead Sciences, INC. | $149.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hsiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.